SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-22-001950
Filing Date
2022-02-24
Accepted
2022-02-24 16:40:22
Documents
90
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K edit-20211231x10k.htm   iXBRL 10-K 2846688
2 EX-10.28 edit-20211231xex10d28.htm EX-10.28 107288
3 EX-23.1 edit-20211231xex23d1.htm EX-23.1 7657
4 EX-31.1 edit-20211231xex31d1.htm EX-31.1 16454
5 EX-31.2 edit-20211231xex31d2.htm EX-31.2 16051
6 EX-32.1 edit-20211231xex32d1.htm EX-32.1 14216
7 GRAPHIC edit-20211231x10k006.jpg GRAPHIC 62165
8 GRAPHIC edit-20211231x10k007.jpg GRAPHIC 27823
9 GRAPHIC edit-20211231xex10d28001.jpg GRAPHIC 1941
  Complete submission text file 0001558370-22-001950.txt   10128405

Data Files

Seq Description Document Type Size
10 EX-101.SCH edit-20211231.xsd EX-101.SCH 58478
11 EX-101.CAL edit-20211231_cal.xml EX-101.CAL 63222
12 EX-101.DEF edit-20211231_def.xml EX-101.DEF 228180
13 EX-101.LAB edit-20211231_lab.xml EX-101.LAB 546257
14 EX-101.PRE edit-20211231_pre.xml EX-101.PRE 420465
84 EXTRACTED XBRL INSTANCE DOCUMENT edit-20211231x10k_htm.xml XML 1644346
Mailing Address 11 HURLEY ST. CAMBRIDGE MA 02141
Business Address 11 HURLEY ST. CAMBRIDGE MA 02141 617-401-9000
Editas Medicine, Inc. (Filer) CIK: 0001650664 (see all company filings)

IRS No.: 464097528 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-37687 | Film No.: 22671784
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences